1. Home
  2. HMY vs CORT Comparison

HMY vs CORT Comparison

Compare HMY & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Gold Mining Company Limited

HMY

Harmony Gold Mining Company Limited

HOLD

Current Price

$15.50

Market Cap

9.8B

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$96.66

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMY
CORT
Founded
1950
1998
Country
South Africa
United States
Employees
34350
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
9.7B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
HMY
CORT
Price
$15.50
$96.66
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$16.00
$96.50
AVG Volume (30 Days)
3.2M
986.3K
Earning Date
02-04-2016
04-30-2026
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$761,407,000.00
Revenue This Year
$37.43
$26.08
Revenue Next Year
$27.44
$26.98
P/E Ratio
$15.60
N/A
Revenue Growth
N/A
12.79
52 Week Low
$13.03
$28.66
52 Week High
$26.04
$95.79

Technical Indicators

Market Signals
Indicator
HMY
CORT
Relative Strength Index (RSI) 48.86 57.67
Support Level $15.27 $76.41
Resistance Level $18.30 $95.11
Average True Range (ATR) 0.44 3.75
MACD 0.09 -0.81
Stochastic Oscillator 49.24 51.19

Price Performance

Historical Comparison
HMY
CORT

About HMY Harmony Gold Mining Company Limited

Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: